Novateor Research Laboratories Ltd.

As of March 31, 2026, Novateor Research Laboratories Ltd. carries a market capitalization of 188.89M, placing it among publicly traded companies globally. Its enterprise value stands at 194.42M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Novateor Research Laboratories Ltd. has 6.05M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Novateor Research Laboratories Ltd. maintains a current ratio of 4.59, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities.

As of the close on October 21, 2026, Novateor Research Laboratories Ltd.'s stock has gained approximately 32.69% over the past 52 weeks. The 50-day moving average sits at 34.89, while the 200-day moving average is 28.64.

As of March 31, 2026, Novateor Research Laboratories Ltd. holds 4.68M in cash and equivalents against 10.22M in total debt, resulting in a net debt position of 5.54M. Total book value stands at 115.03M, with working capital of 85.64M providing operational flexibility.